Fulcrum Therapeutics, Inc. (FULC)

Fulcrum Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	191	254	417	379	717	319
Market Cap Growth	-39.25%	-39.25%	10.13%	-47.15%	124.42%	-14.89%
Enterprise Value	-42	5	172	171	477	192
Last Close Price	3.53	4.70	6.75	7.28	17.69	11.71
PS Ratio	2.74	3.17	148.77	59.75	37.41	36.21
PB Ratio	0.78	1.04	1.77	1.91	3.39	3.36
P/TBV Ratio	0.78	1.04	1.77	1.91	3.39	3.36
EV/Sales Ratio	-	0.07	61.21	26.99	24.87	21.82
Debt / Equity Ratio	0.04	0.04	0.05	0.07	-	0
Asset Turnover	0.31	0.31	0.01	0.03	0.11	0.07
Quick Ratio	22.13	22.13	17.44	12.20	11.58	4.33
Current Ratio	22.63	22.63	17.71	12.41	11.77	4.47
Return on Equity (ROE)	-4.07%	-4.07%	-44.84%	-53.53%	-52.72%	-77.68%
Return on Assets (ROA)	-4.78%	-4.78%	-28.56%	-30.36%	-27.79%	-37.30%
Return on Capital (ROIC)	-4.98%	-4.98%	-30.18%	-33.07%	-33.03%	-49.08%
Earnings Yield	-5.10%	-3.84%	-23.33%	-28.99%	-11.28%	-22.17%
FCF Yield	-1.31%	-0.98%	-21.92%	-26.13%	-11.19%	-17.21%
Buyback Yield / Dilution	-1.10%	-1.10%	-36.27%	-27.23%	-39.47%	-129.53%

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q